Literature DB >> 3683478

Effectiveness of adenoidectomy and tympanostomy tubes in the treatment of chronic otitis media with effusion.

G A Gates1, C A Avery, T J Prihoda, J C Cooper.   

Abstract

To study the effectiveness of adenoidectomy and of the placement of tympanostomy tubes in the treatment of chronic otitis media with effusion, we randomly assigned 578 children, aged four through eight years, to receive bilateral myringotomy and no additional treatment (Group 1), placement of tympanostomy tubes (Group 2), adenoidectomy (Group 3), or adenoidectomy and placement of tympanostomy tubes (Group 4). The 491 children who underwent one of these treatments were examined at six-week intervals for up to two years. The mean time spent with effusion of any type in either ear over the two-year follow-up in the four groups was 51, 36, 31, and 27 weeks, respectively (P less than 0.0001), comparing Group 1 with each of the other groups. Hearing was equivalent in Groups 2, 3, and 4, and was significantly better than in Group 1. The most frequent sequela, purulent otorrhea, occurred one or more times in 22, 29, 11, and 24 percent of the subjects in Groups 1, 2, 3, and 4, respectively (P less than 0.001). Adenoidectomy plus bilateral myringotomy lowered the overall post-treatment morbidity (as measured by hearing acuity in the most severely affected ear [P = 0.0174] and the number of surgical retreatments required [P = 0.009]) more than did tympanostomy tubes alone and to the same degree as did adenoidectomy and tympanostomy tubes. We conclude that adenoidectomy should be considered when surgical therapy is indicated in children four to eight years old who are severely affected by chronic otitis media with effusion.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3683478     DOI: 10.1056/NEJM198712033172305

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  31 in total

1.  Otitis media with effusion in infants: is screening and treatment with ventilation tubes necessary?

Authors:  M M Rovers; K Ingels; G J van der Wilt; G A Zielhuis; P van den Broek
Journal:  CMAJ       Date:  2001-10-16       Impact factor: 8.262

Review 2.  Otitis media of childhood.

Authors:  S Mehta; Y N Mehra
Journal:  Indian J Pediatr       Date:  1992 May-Jun       Impact factor: 1.967

Review 3.  Role of adenoidectomy in otitis media and respiratory function.

Authors:  Petri S Mattila
Journal:  Curr Allergy Asthma Rep       Date:  2010-11       Impact factor: 4.806

Review 4.  Adenoidectomy for recurrent or chronic nasal symptoms in children.

Authors:  Maaike Ta van den Aardweg; Anne Gm Schilder; Ellen Herkert; Chantal Wb Boonacker; Maroeska M Rovers
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

5.  A randomised controlled trial of surgery for glue ear.

Authors:  N A Black; C F Sanderson; A P Freeland; M P Vessey
Journal:  BMJ       Date:  1990-06-16

6.  Lymphoid and non-lymphoid cells in the adenoid of children with otitis media with effusion: a comparative study.

Authors:  E B van Nieuwkerk; C J de Wolf; E W Kamperdijk; S van der Baan
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

Review 7.  Middle ear effusion in children.

Authors:  A T Cheng; N M Young
Journal:  Indian J Pediatr       Date:  1997 Nov-Dec       Impact factor: 1.967

8.  Peripheral blood immunological parameters of children with adenoid hypertrophy with otitis media with effusion: propensity score matching.

Authors:  Wen Yang; Yu Zhao; Jing Wang; Xiao-Hong Yan; Tian Shen; Yixin Qiao; Jianjun Ren; Danni Cheng; Min Chen
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-08-30       Impact factor: 2.503

9.  Speech and language delay in children: a case to learn from.

Authors:  Nicola Wooles; Joanna Swann; Emma Hoskison
Journal:  Br J Gen Pract       Date:  2018-01       Impact factor: 5.386

10.  Immunological status in the aetiology of recurrent otitis media with effusion: serum immunoglobulin levels, functional mannose-binding lectin and Fc receptor polymorphisms for IgG.

Authors:  Masja Straetemans; Selma P Wiertsema; Elisabeth A M Sanders; Ger T Rijkers; Kees Graamans; Bert van der Baan; Gerhard A Zielhuis
Journal:  J Clin Immunol       Date:  2005-01       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.